Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 Articles of Association
- 10.1 English Translation of Sales Agreement Between the Top Wealth Group (International) Limited and Sunfun (China) LTD., Dated December 30, 2021
- 10.2 English Translation of Sales Agreement Between the Top Wealth Group (International) Limited and Mother Nature Health (HK) Limited, Dated December 30, 2021.
- 10.3 English Translation of Sales Agreement Between Top Wealth Group (International) Limited and Channel Power Limited, Dated December 19, 2021
- 10.4 English Translation of Sales Agreement Between Top Wealth Group (International) Limited and Beauty & Health International Company Limited, Dated December 30, 2021
- 10.5 English Translation of Sales Agreement Between Top Wealth Group (International) Limited and Beauty & Health International E-commerce Limited, Dated September 1, 2022
- 10.6 English Translation of Sales Agreement Between Top Wealth Group (International) Limited and Healthkitpro International Limited, Dated December 18, 2021
- 10.7 Employment Agreement Between Top Wealth Group (International) Limited and Kwok Kuen Yuen, Registrant's Chief Financial Officer, Dated 20 November 2022
- 10.8 Employment Agreement Between the Registrant and Kwok Kuen, Yuen, Registrant's Chief Financial Officer, Dated May 16, 2023
- 10.9 English Translation of Appointment Letter of Kim Kwan Kings, Wong As the President of Top Wealth Group (International) Limited, Dated September 1, 2022
- 10.10 Director Agreement Between the Registrant and Kim Kwan Kings, Wong, Registrant's Director, Chief Executive Officer and Chairman of the Board, Dated May 16, 2023
- 10.11 English Translation of Corporate Development Consultant Appointment Agreement Between the Company and the Consultant Haitong Chen, Dated August 1, 2022
- 10.12 English Translation of Caviar Sales Agreement Between the Top Wealth Group (International) Limited and Fujian Aoxuanlaisi Biotechnology Co. LTD., Dated April 30, 2022
- 10.13 English Translation of Power of Attorney Granted Under the Caviar Sales Agreement by Fujian Aoxuanlaisi Biotechnology Co. LTD. to Top Wealth Group (International) Limited, Dated April 30, 2022
- 10.14 English Translation of Food Processing Factory Leasing and Service Project Agreement Between Top Wealth Group (International) Limited and Sunfun (China) Limited, Dated February 11, 2023
- 10.15 English Translation of Food Processing Factory Leasing and Service Project Agreement Between the Top Wealth Group (International) Limited and Sunfun (China) Limited, Dated July 31, 2021
- 10.16 English Translation of the Form of Sales Agreement of Top Wealth Group (International) Limited for Its Distributors
- 10.17 English Translation of Sales Agreement for Caviar Between Fujian Longhuang Biotech Co. Limited and Fujian Aoxuanlaisi Biotechnology Co. LTD., Dated December 10, 2020
- 10.18 English Translation of Power of Attorney Granted Under the Sales Agreement for Caviar by Fujian Longhuang Biotech Co. Limited to Fujian Aoxuanlaisi Biotechnology Co. LTD., Dated December 10, 2020
- 10.19 Director Agreement Between the Registrant and Hung, Cheung, Registrant's Director, Dated October 27, 2023
- 10.20 English Translation of the Letter of Employment Between Top Wealth Group (International) Limited and Hung, Cheung, Dated June 25, 2022
- 10.21 Form of the Independent Non-executive Director Offer Letter
- 14.1 Code of Business Conduct and Ethics
- 21.1 List of Subsidiaries
- 23.1 Consent of Onestop Assurance Pac
- 23.4 Consent of Allbright Law Offices
- 99.1 Audit Committee Charter
- 99.2 Nominating Committee Charter
- 99.3 Compensation Committee Charter
- 99.4 Consent from Frost & Sullivan Regarding the Company's Citation of Industry Data Possessed by Frost & Sullivan
- 99.5 Consent of Feiyong, Li, Independent Director Nominee
- 99.6 Consent of Phei Suan, Ho, Independent Director Nominee
- 99.7 Consent of Yeung Tak, Chen, Independent Director Nominee
- EX-FILING FEES Filing Fee Table
Associated filings
- 16 Apr 24 424B4 Prospectus supplement with pricing info
- 1 Apr 24 EFFECT Notice of effectiveness
- 27 Mar 24 F-1/A Registration statement (foreign) (amended)
- 12 Feb 24 FWP Free writing prospectus
- 9 Feb 24 F-1/A Registration statement (foreign) (amended)
- 11 Jan 24 F-1/A Registration statement (foreign) (amended)
- 5 Jan 24 F-1/A Registration statement (foreign) (amended)
- 18 Dec 23 F-1/A Registration statement (foreign) (amended)
-
21 Nov 23 F-1 Registration statement (foreign)
TWG similar filings
Filing view
External links
Exhibit 107
Calculation of Filing Fee Tables
F-1
(Form Type)
Top Wealth Group Holding Limited
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Ordinary Shares, par value US$0.0001 per share (1) | 457(o) | 2,000,000 | $ | 6.00 | 12,000,000 | $ | 0.00014760 | $ | 1,771.2 | |||||||||||||||||||||||||||||||
Fees Previously Paid | Equity | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||
Total Offering Amounts | $ | 12,000,000 | ||||||||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | - | |||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | - | |||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | 1771.2 |
(1) | The registration fee for securities is based on an estimate of the Proposed Maximum Aggregate Offering Price of the securities, assuming the sale of the maximum number of shares at the highest expected offering price, and such estimate is solely for the purpose of calculating the registration fee pursuant to Rule 457(o). In accordance with Rule 416(a), the Registrant is also registering an indeterminate number of additional Ordinary Shares that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions. |